On December 2-4, 2012, BIT's 2nd World Congress of MolMed-2012 was held successfully in Guangzhou, China.
Participants from academic, industrial professionals and key-decision makers delivered the new achievement on their research, together discussed and analysis the development of molecular medicine.
As the keynote speakers, Dr. James B. Hicks, Research Professor and Director, Cold Spring Harbor Laboratory, USA; Dr. Hemchandra M. Shertukde, President, Diagnostic Devices Inc., USA; Dr. Mahmood Moshiri, President/CEO, Panacea Global Inc., Canada; Dr. Karen Long, VP, Abbott Molecular Inc., USA; Dr. Peng Zhou, CSO, Rheonix, Inc., USA made excellent presentations and warmly discussed with the audiences at keynote forum.
Depending on the warmly support and good suggestions from all of the participants, we are confident in organizing MolMed-2013 which would be better and more successful than MolMed-2012.
★ Event Report
★ Introduction of MolMed-2012
★ Highlights of the Conference
★ Renowned Speakers
★ Past Event Report
BIT's 2nd Annual Congress of Biomarkers
|BIT’s 4th Annual Congress and Exposition of
Molecular Diagnostics (CEMD-2011)
|Information Research Center of International Talents, SAFEA|
|China Medicinal Biotech Association|
|BIT Congress Inc.|
|Foreign Experts Databank
of SAFEA-Dalian Biotechnological and Medical Experts Subdivision